Ward J M, Stevens J L, Konishi N, Kurata Y, Uno H, Diwan B A, Ohmori T
Tumor Pathology and Pathogenesis Section, National Cancer Institute, Frederick Cancer Research and Development Center, MD 21702-1201.
Am J Pathol. 1992 Oct;141(4):955-64.
Vimentin expression was studied immunohistochemically in renal cortical tubules of untreated male rats of various ages, rats exposed to toxins (barbital sodium, folic acid) and carcinogens (streptozotocin, N-bis(2-hydroxypropyl)nitrosamine, barbital sodium, and in humans of various ages with or without renal epithelial tumors. Fetal, neonatal, and young adult rats did not express vimentin in renal cortical tubules. Regenerative renal tubular lesions from rats with aging nephropathy and from rats with toxic nephropathy both expressed vimentin. Mitogenic lesions induced by folic acid at 24 hours, however, were not immunoreactive for vimentin. Carcinogen-induced preneoplastic renal cortical tubular lesions in rats were most often focally immunoreactive whereas strong vimentin expression was found in almost all induced renal tumors. In kidneys of three children (younger than 2 years of age), vimentin was not found in renal cortical tubular cells except in rare individual cells in one case. Vimentin was abundant in basophilic regenerative tubules in kidneys of aged individuals, however. Most (7/10) human renal carcinomas and latent preneoplastic or neoplastic renal tubular lesions found incidentally at autopsy (2/4) showed vimentin expression. The authors suggest that the switching to vimentin expression in phenotypically normal renal cortical tubular cells in rats and humans, which do not usually express the intermediate filament protein vimentin, should be considered vimentin metaplasia. Vimentin expression is dissociated from increased cell proliferation in hyperplastic and neoplastic lesions, however. Instead the degree of dedifferentiation of the tubule cells and changes in phenotype were associated with vimentin expression.
采用免疫组织化学方法研究了不同年龄未处理雄性大鼠、接触毒素(巴比妥钠、叶酸)和致癌物(链脲佐菌素、N-双(2-羟丙基)亚硝胺、巴比妥钠)的大鼠以及不同年龄有或无肾上皮肿瘤的人类肾皮质小管中的波形蛋白表达。胎儿、新生儿和年轻成年大鼠的肾皮质小管中不表达波形蛋白。衰老性肾病大鼠和中毒性肾病大鼠的再生肾小管病变均表达波形蛋白。然而,叶酸在24小时诱导的有丝分裂性病变对波形蛋白无免疫反应性。致癌物诱导的大鼠肾皮质小管癌前病变最常呈局灶性免疫反应性,而在几乎所有诱导的肾肿瘤中均发现波形蛋白强表达。在3名儿童(2岁以下)的肾脏中,除1例罕见的个别细胞外,肾皮质小管细胞中未发现波形蛋白。然而,在老年人肾脏的嗜碱性再生小管中波形蛋白丰富。大多数(7/10)人类肾癌以及尸检时偶然发现的潜在癌前或肿瘤性肾小管病变(2/4)显示波形蛋白表达。作者认为,在通常不表达中间丝蛋白波形蛋白的大鼠和人类的表型正常的肾皮质小管细胞中,向波形蛋白表达的转变应被视为波形蛋白化生。然而,波形蛋白表达与增生性和肿瘤性病变中细胞增殖增加无关。相反,小管细胞的去分化程度和表型变化与波形蛋白表达相关。